Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy

Ching-Lan Lu Department of Internal Medicine; National Taiwan University Hospital Hsin-Chu Branch; Hsin-Chu, Taiwan

Chien-Ching Hung Department of Internal Medicine; National Taiwan University Hospital and National Taiwan University College of Medicine; Taipei, TaiwanCorrespondence[email protected] [email protected]

Yu-Chung Chuang Department of Internal Medicine; National Taiwan University Hospital and National Taiwan University College of Medicine; Taipei, Taiwan

Wen-Chun Liu Department of Internal Medicine; National Taiwan University Hospital and National Taiwan University College of Medicine; Taipei, Taiwan

Chin-Ting Su Department of Clinical Laboratory Sciences and Medical Biotechnology; National Taiwan University College of Medicine; Taipei, Taiwan

Yi-Ching Su Department of Clinical Laboratory Sciences and Medical Biotechnology; National Taiwan University College of Medicine; Taipei, Taiwan

Shu-Fang Chang Department of Clinical Laboratory Sciences and Medical Biotechnology; National Taiwan University College of Medicine; Taipei, Taiwan

Sui-Yuan Chang Department of Clinical Laboratory Sciences and Medical Biotechnology; National Taiwan University College of Medicine; Taipei, Taiwan; Department of Laboratory Medicine; National Taiwan University Hospital and National Taiwan University College of Medicine; Taipei, TaiwanCorrespondence[email protected] [email protected]

Shan-Chwen Chang Department of Internal Medicine; National Taiwan University Hospital and National Taiwan University College of Medicine; Taipei, Taiwan

show all

Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date